Singapore Busts Illicit Vape Production; Suspect Charged with Five Offenses

Jul.18.2025
Singapore Busts Illicit Vape Production; Suspect Charged with Five Offenses
A 41-year-old man in Singapore has been charged with multiple offenses, including violations of the Tobacco (Control of Advertisements and Sale) Act and the Poisons Act, for allegedly manufacturing e-cigarettes containing the controlled substance etizolam at his residence.

Key points:

 

·A 41-year-old man in Singapore is facing charges for allegedly manufacturing e-cigarettes containing drugs. 

 

·He is accused of violating the Tobacco (Control of Advertisements and Sale) Act. Over a thousand e-cigarette components and a large quantity of empty pods were seized from him. 

 

·The man has expressed his intention to plead guilty and is scheduled to appear in court on July 23rd.

 


【2Firsts News Flash】According to a report by Malaymail on July 17, a 41-year-old man in Singapore is being accused of illegally manufacturing e-cigarettes containing drugs in his home. The defendant, Mohammed Akil Abdul Rahim, is facing five charges under the Tobacco (Control of Advertisements and Sale) Act for allegedly manufacturing e-cigarettes in a block of flats in Yishun.

 

The accusation documents show that on December 11, 2024, law enforcement officers found 569 empty pod casings, 534 components, 1,485 pod covers, and 100 electronic pods at his residence. These tools and materials are believed to be used in the manufacturing of Kpodspods laced with fentanyl, which has garnered increasing public concern.

 

The prosecutor from the Health Sciences Authority (HSA) in Singapore told the court that they have prepared a plea agreement for the case. The defendant appeared in court via video link and expressed willingness to plead guilty to all charges, and stated that he does not plan to hire a lawyer.

 

The man was previously charged under the Poisons Act for possession and sale of the controlled hospital-grade sedative, etomidate. It is alleged that he sold 100 electronic pods containing the substance at the same location just past midnight on December 11. He was found in possession of 26.4 grams of white powder testing positive for the substance at around 5:30am that same morning.

 

Propofol is commonly used for intravenous sedation in medical procedures, but if inhaled or ingested, it can lead to serious side effects including seizures, difficulty breathing, and confusion.

 

In addition, the defendant also faces charges under the Passport Act for falsely claiming to the Immigration and Checkpoints Authority in January 2025 that he had lost his passport at a coffee shop. He has been in custody since June 20 and is expected to plead guilty on July 23.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.
May.06 by 2FIRSTS.ai
Special Report | Russian Vape Compromise Faces First Hurdles
Special Report | Russian Vape Compromise Faces First Hurdles
Russia’s regional vape-ban model is facing early legal and political tests, as Perm Krai moves ahead before federal legislation is fully adopted. The case highlights uncertainty over regional authority, concerns from business groups about market fragmentation, and the risk that pressure against regional bans could revive calls for a stricter nationwide prohibition.
Industry Insight
May.28
 BAT Bangladesh Cigarette Sales Fall 14%, Q1 Profit Drops 34%
BAT Bangladesh Cigarette Sales Fall 14%, Q1 Profit Drops 34%
British American Tobacco Bangladesh reported a 14% year-on-year decline in cigarette sales volume and a 34% drop in first-quarter profit, highlighting mounting pressure from inflation, taxation, and weakening consumer spending in Bangladesh.
News
May.18
AIR Romania Manufacturing Facility Expected to Begin Operations in Q1 2027
AIR Romania Manufacturing Facility Expected to Begin Operations in Q1 2027
AIR Limited announced on May 7, 2026, that it plans to open a new manufacturing facility of approximately 70,000 square feet in Stefanesti, Bucharest North, Romania. The facility is expected to begin operations by the first quarter of 2027. AIR said that once fully operational, the facility is expected to support more than 150 jobs and be capable of producing more than 4,000 tons of flavored shisha molasses each year.
May.08 by 2FIRSTS.ai
Belgium Approves Vape Flavor Ban, Allowing Only Tobacco-Flavored and Unflavored Products From September 2028
Belgium Approves Vape Flavor Ban, Allowing Only Tobacco-Flavored and Unflavored Products From September 2028
Belgium’s federal government on Thursday approved a ban on flavored vapes, allowing only tobacco-flavored and unflavored e-cigarettes on the market from September 2028. Health Minister Frank Vandenbroucke said the measure is aimed at protecting the health of children and young people and preventing a new generation from becoming dependent on tobacco.
May.06 by 2FIRSTS.ai
AIR Expects to Complete CAEP Business Combination in Q2 2026 and List on Nasdaq
AIR Expects to Complete CAEP Business Combination in Q2 2026 and List on Nasdaq
AIR Limited and Cantor Equity Partners III announced that the F-4 registration statement related to their proposed business combination was declared effective by the U.S. Securities and Exchange Commission on April 22, 2026. Under the arrangement first announced on Nov. 7, 2025, the combined company, AIR Global PLC, is intended to list on Nasdaq in the United States under the ticker “AIIR.”
Apr.24 by 2FIRSTS.ai